Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT

Abstract

To directly evaluate prehepatic secretion of pancreatic hormones during a 3-h oral glucose tolerance test (OGTT), we measured insulin and C-peptide in six healthy control, six obese, and six type 2 diabetic subjects in the femoral artery and hepatic vein by means of the hepatic catheterization technique. Hypersecretion in obesity was confirmed (309 ± 66 nmol in obese vs. 117 ± 22 in control and 79 ± 13 in diabetic subjects, P ≤ 0.01), whereas early phase secretion was impaired in diabetes. We also measured hepatic insulin extraction (higher in diabetic than in control subjects, P = 0.03) and insulin clearance. The measured data were also used to validate a previously proposed mathematical model, developed to quantify prehepatic secretion, hepatic insulin extraction, and insulin clearance during OGTT, when C-peptide and insulin concentrations are systemically measured. We found good correspondence between experimental data and model estimates for prehepatic insulin secretion ( P > 0.3, r 2 = 0.93), whereas estimation of hepatic insulin extraction and insulin clearance needs further investigation for improvement.